196 related articles for article (PubMed ID: 32060857)
1. Hydroxysafflor Yellow A Confers Neuroprotection from Focal Cerebral Ischemia by Modulating the Crosstalk Between JAK2/STAT3 and SOCS3 Signaling Pathways.
Yu L; Liu Z; He W; Chen H; Lai Z; Duan Y; Cao X; Tao J; Xu C; Zhang Q; Zhao Z; Zhang J
Cell Mol Neurobiol; 2020 Nov; 40(8):1271-1281. PubMed ID: 32060857
[TBL] [Abstract][Full Text] [Related]
2. Hydroxysafflor Yellow A and Tenuigenin Exhibit Neuroprotection Effects Against Focal Cerebral Ischemia Via Differential Regulation of JAK2/STAT3 and SOCS3 Signaling Interaction.
Yu L; Zhang C; Gu L; Chen H; Huo Y; Wang S; Tao J; Xu C; Zhang Q; Ma M; Zhang J
Mol Neurobiol; 2024 Jan; ():. PubMed ID: 38214838
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of hydroxysafflor yellow A on focal cerebral ischemic injury in rats and its primary mechanisms.
Zhu HB; Zhang L; Wang ZH; Tian JW; Fu FH; Liu K; Li CL
J Asian Nat Prod Res; 2005 Aug; 7(4):607-13. PubMed ID: 16087635
[TBL] [Abstract][Full Text] [Related]
4. Capacity of HSYA to inhibit nitrotyrosine formation induced by focal ischemic brain injury.
Sun L; Yang L; Fu Y; Han J; Xu Y; Liang H; Cheng Y
Nitric Oxide; 2013 Nov; 35():144-51. PubMed ID: 24126016
[TBL] [Abstract][Full Text] [Related]
5. AKT-related autophagy contributes to the neuroprotective efficacy of hydroxysafflor yellow A against ischemic stroke in rats.
Qi Z; Yan F; Shi W; Zhang C; Dong W; Zhao Y; Shen J; Ji X; Liu KJ; Luo Y
Transl Stroke Res; 2014 Aug; 5(4):501-9. PubMed ID: 24804941
[TBL] [Abstract][Full Text] [Related]
6. Hydroxy-safflor yellow A attenuates Aβ₁₋₄₂-induced inflammation by modulating the JAK2/STAT3/NF-κB pathway.
Zhang ZH; Yu LJ; Hui XC; Wu ZZ; Yin KL; Yang H; Xu Y
Brain Res; 2014 May; 1563():72-80. PubMed ID: 24690200
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of hydroxysafflor yellow A: in vivo and in vitro studies.
Zhu H; Wang Z; Ma C; Tian J; Fu F; Li C; Guo D; Roeder E; Liu K
Planta Med; 2003 May; 69(5):429-33. PubMed ID: 12802724
[TBL] [Abstract][Full Text] [Related]
8. [Research progress on mechanism of Carthamus tinctorius in ischemic stroke therapy].
Chen JR; Xie XF; Cao XY; Li GM; Yin YP; Peng C
Zhongguo Zhong Yao Za Zhi; 2022 Sep; 47(17):4574-4582. PubMed ID: 36164862
[TBL] [Abstract][Full Text] [Related]
9. Protective cerebrovascular effects of hydroxysafflor yellow A (HSYA) on ischemic stroke.
Sun Y; Xu DP; Qin Z; Wang PY; Hu BH; Yu JG; Zhao Y; Cai B; Chen YL; Lu M; Liu JG; Liu X
Eur J Pharmacol; 2018 Jan; 818():604-609. PubMed ID: 29166571
[TBL] [Abstract][Full Text] [Related]
10. Hydroxysafflor yellow A exerts neuroprotective effects in cerebral ischemia reperfusion-injured mice by suppressing the innate immune TLR4-inducing pathway.
Lv Y; Qian Y; Fu L; Chen X; Zhong H; Wei X
Eur J Pharmacol; 2015 Dec; 769():324-32. PubMed ID: 26607471
[TBL] [Abstract][Full Text] [Related]
11. Hydroxy-safflor yellow A inhibits neuroinflammation mediated by Aβ₁₋₄₂ in BV-2 cells.
Zhang Z; Wu Z; Zhu X; Hui X; Pan J; Xu Y
Neurosci Lett; 2014 Mar; 562():39-44. PubMed ID: 24412680
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of hydroxysafflor yellow A alone or in combination with acetylglutamine on cerebral ischemia reperfusion injury in rat: A PET study using
Deng L; Wan H; Zhou H; Yu L; He Y
Eur J Pharmacol; 2018 Apr; 825():119-132. PubMed ID: 29438705
[TBL] [Abstract][Full Text] [Related]
13. Hydroxysafflor yellow A alleviates cerebral ischemia reperfusion injury by suppressing apoptosis via mitochondrial permeability transition pore.
Huang P; Wu SP; Wang N; Seto S; Chang D
Phytomedicine; 2021 May; 85():153532. PubMed ID: 33735723
[TBL] [Abstract][Full Text] [Related]
14. Proteomic Analysis of Hydroxysafflor Yellow A Against Cerebral Ischemia/Reperfusion Injury in Rats.
Xu H; Liu T; Wang W; Su N; Yang L; Yang Z; Dou F; Cui J; Fei F; Ma J; Wen A; Ding Y
Rejuvenation Res; 2019 Dec; 22(6):503-512. PubMed ID: 30712471
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotection of hydroxysafflor yellow A in experimental cerebral ischemia/reperfusion injury via metabolic inhibition of phenylalanine and mitochondrial biogenesis.
Chen S; Sun M; Zhao X; Yang Z; Liu W; Cao J; Qiao Y; Luo X; Wen A
Mol Med Rep; 2019 Apr; 19(4):3009-3020. PubMed ID: 30816517
[TBL] [Abstract][Full Text] [Related]
16. STAT3 inhibitor WP1066 as a novel therapeutic agent for bCCI neuropathic pain rats.
Xue ZJ; Shen L; Wang ZY; Hui SY; Huang YG; Ma C
Brain Res; 2014 Oct; 1583():79-88. PubMed ID: 25084036
[TBL] [Abstract][Full Text] [Related]
17. [Protective effect of hydroxysafflor yellow A on experimental cerebral ischemia in rats].
Zhu HB; Wang ZH; Tian JW; Fu FH; Liu K; Li CL
Yao Xue Xue Bao; 2005 Dec; 40(12):1144-6. PubMed ID: 16496682
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotection of hydroxysafflor yellow A in the transient focal ischemia: inhibition of protein oxidation/nitration, 12/15-lipoxygenase and blood-brain barrier disruption.
Sun L; Yang L; Xu YW; Liang H; Han J; Zhao RJ; Cheng Y
Brain Res; 2012 Sep; 1473():227-35. PubMed ID: 22867942
[TBL] [Abstract][Full Text] [Related]
19. Ohwia caudata extract relieves the IL-17A-induced inflammatory response of synoviocytes through modulation of SOCS3 and JAK2/STAT3 activation.
Lu CY; Kuo CH; Kuo WW; Hsieh DJ; Wang TF; Shih CY; Lin PY; Lin SZ; Ho TJ; Huang CY
Environ Toxicol; 2023 Aug; 38(8):1914-1924. PubMed ID: 37163279
[TBL] [Abstract][Full Text] [Related]
20. Hydroxysafflor Yellow A Protects Neurons From Excitotoxic Death through Inhibition of NMDARs.
Wang X; Ma Z; Fu Z; Gao S; Yang L; Jin Y; Sun H; Wang C; Fan W; Chen L; Zheng QY; Bi G; Ma CL
ASN Neuro; 2016; 8(2):. PubMed ID: 27067428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
